MicroRNAs 146a and 147b biomarkers for colorectal tumor's localization

Inés Omrane1, Nadia Kourda2, Nejla Stambouli1

  • 1Laboratory of Human Genetics Immunology and Pathology, Faculty of Sciences,Tunis El Manar University, 2092 Tunis, Tunisia.

Insights

MicroRNAs (miRs) show altered expression in colorectal cancer. Specific miRs like miR21, miR146a, and miR135a are upregulated in tumors, with miR146a potentially marking left-sided colon cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRs) are a newly identified class of molecules implicated in various cancers.
  • The specific roles of five miRs (miR146a, miR155, miR21, miR135a, and miR147b) in colorectal cancer pathogenesis are not fully understood.

Purpose of the Study:

  • To investigate the expression levels of five specific miRs in colorectal cancer tissues and normal adjacent tissues.
  • To explore potential differences in miR expression between left and right colon tumors.
  • To identify correlations between miR expression in tumor and healthy tissues based on cancer localization.

Main Methods:

  • Quantitative real-time PCR was used to measure the expression of miR146a, miR155, miR21, miR135a, and miR147b.
  • Expression levels were analyzed in 25 pairs of matched colon cancer and normal colon mucosa samples.
  • Statistical analysis was performed to assess correlations and differences in expression based on tumor location.

Main Results:

  • miR21, miR146a, and miR135a showed significantly higher expression in colon tumors compared to normal tissues.
  • miR146a and miR147b expression was notably higher in left-sided colon tumors than in right-sided tumors.
  • Inverse correlations were observed between miR expression in tumor and healthy tissues, varying by cancer location.

Conclusions:

  • The findings suggest distinct mechanisms regulate miR expression in left and right colon cancers.
  • miR146a may serve as a potential biomarker for left-sided colon tumors.
  • The study indicates that colorectal carcinogenesis pathways may differ based on tumor location.